48.JPG)
Cell Free RNA Isolation & Extraction Kits Market Size is valued at USD 47.1 million in 2024 and is predicted to reach USD 188.6 million by the year 2034 at a 15.0% CAGR during the forecast period for 2025-2034
Key Industry Insights & Findings from the Report:
RNA extraction kits isolate the RNA from any cell, which can be extracted from an animal, a bacterium, or a plant. These extractions are mostly used for RNA profiling different species to comprehend them better and, in certain cases, to identify the unidentified organism. Technological developments, the introduction of new products by major market participants, and increasing cancer incidence worldwide may also aid the market's expansion.
A decline in patient turnout for testing as a result of COVID-19 has had an impact on the diagnostic tests for other diseases and medical disorders in hospitals and other clinical diagnostics establishments. However, the high COVID-19 infection rate and important local company research initiatives raising rates of various cancer kinds and an increase in cases of prenatal problems are the main factors driving the market development.
The market for cell-free RNA isolation and extraction kits is well-established. It plays a significant role in medical decision-making by assisting in gathering data for disseminating various treatments, underscoring its importance in healthcare. A growing elderly population base, extensive research & innovation, patient population knowledge of non-invasive and minimally invasive procedures, increased government funding, and technical improvements are further drivers boosting the market's growth.
The Cell-free RNA isolation & extraction kits market is segmented on the applications and end-use. The market is segmented based on applications: oncology, prenatal screening, metabolic disorders, and others. Based on end-use, the market is further segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others.
The market's leading segment is parental screening. The use of non-invasive methods like cell-free RNA, which aids in predicting prenatal problems, is advancing quickly. Cell-free RNA can be used to describe and predict prenatal problems such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) (cf RNA). Thus, the rise in demand for cell-free RNA isolation and extraction kits is boosting the market demand due to the rise in women experiencing prenatal problems.
Hospitals grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time due to the growing need for precise and early disease diagnosis. Techniques for isolating and purifying RNA are thought to be efficient screening tools for hereditary illnesses such as sickle cell anemia, hemophilia A, and Tay-Sachs disease. Therefore, the availability of such effective technologies at moderate to cheap prices will likely improve the adoption rate of these technologies in medical facilities and hospitals.
The North American cell-free RNA isolation & extraction kits Industry is expected to register the highest market share in revenue soon. The main factor driving market expansion in the area is the presence of established companies and their work on creating technologically cutting-edge fast purification and isolation systems. Additionally, the increasing financing initiatives for biotechnology research are accelerating the market's growth.
In addition, Asia Pacific is projected to grow rapidly in the global cell-free RNA isolation & extraction kits business. Rising economic growth, substantial life sciences research, an increasing patient population, supportive government measures, and numerous creative biotech companies in the area are all factors causing the market in the region to flourish.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 47.1 Mn |
|
Revenue forecast in 2034 |
USD 188.6 Mn |
|
Growth rate CAGR |
CAGR of 15.0% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Applications And End-Use |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell Free RNA Isolation & Extraction Kits Market Snapshot
Chapter 4. Global Cell Free RNA Isolation & Extraction Kits Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis
5.1. by Application & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
5.2.1. Oncology
5.2.2. Prenatal Screening
5.2.3. Metabolic Disorders
5.2.4. Others
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-users:
6.2.1. Hospitals & Clinics
6.2.2. Pharmaceutical & Biotechnology Companies
6.2.3. Others
Chapter 7. Cell Free RNA Isolation & Extraction Kits Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.1.2. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.1.3. North America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.2.2. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.2.3. Europe Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.3.2. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.3.3. Asia Pacific Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.4.2. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.4.3. Latin America Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.5.2. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.5.3. Middle East & Africa Cell Free RNA Isolation & Extraction Kits Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Aline Biosciences
8.2.2. Apostle Inc. (Apostle Sciences)
8.2.3. Danagen-Bioted, S.L.
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.5. JBS Science Inc.
8.2.6. Norgen Biotek Corp
8.2.7. PerkinElmer, Inc.
8.2.8. Promega Corporation
8.2.9. QIAGEN N.V.
8.2.10. Streck, Inc.
8.2.11. Takara Bio Inc.
8.2.12. Thermo Fisher Scientific Inc.
8.2.13. Zymo Research Corporation
8.2.14. Other Prominent Players
Cell Free RNA Isolation & Extraction Kits Market By Application-
Cell Free RNA Isolation & Extraction Kits Market By End User-
Cell Free RNA Isolation & Extraction Kits Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
